C07K 14/5415
Leukaemia inhibitory factor [lif]
Official title: {Leukaemia inhibitory factor [LIF]}
C07K14/5415 (Leukaemia inhibitory factor [lif]) appears on 30 US grants and 31 published applications in this corpus.
Search patents in C07K- Granted patents
- 30
- Published applications
- 31
- Assignees
- 23
- Inventors
- 80
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 2 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 1 | 3 |
| 2010 | 4 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 5 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 4 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for stimulating the gene expression in endometrial cells2 Dec 2025US 12,486,500 B2Telea Medical Group S.R.L.
- Retinal protective factor 2 (RPF2) protein delivered by adeno-associated virus expression29 Jul 2025US 12,370,269 B2University of Florida Research Foundation, Inc.
- Three-dimensional micro-environment structure for controlling cell behavior, three-dimensional surface for controlling cell behavior, and method for manufacturing array and three-dimensional micro-environment structure20 May 2025US 12,305,193 B2Amolifescience Co., Ltd.
- MSC-NTF specific exosomes and use thereof25 Feb 2025US 12,233,092 B2BrainStorm Cell Therapeutics Ltd.
- Kit for immunological detection of TNF-alpha, sTNFR1 and IL-8 in prostate cancer27 Aug 2019US 10,393,746 B2Health Research, Inc.
- Retinal protective factor 2 (rpf2) protein delivered by adeno-associated virus expression19 Jun 2025US 2025/0195696 A1University of Florida Research Foundation, Inc.
- Msc-ntf specific exosomes and use thereof24 Apr 2025US 2025/0127819 A1BrainStorm Cell Therapeutics Ltd.
- Methods and compositions for preventing or treating cancer27 Feb 2025US 2025/0066438 A1
- Method for Stimulating the Gene Expression in Endometrial Cells4 Jul 2024US 2024/0218349 A1Telea Electronic Engineering S.r.l.
- Dna construct for targeting therapeutic molecules to diseased tissue by immune cells24 Nov 2022US 2022/0372511 A1The Regents of the University of California
Most cited
By later US patents
- Leukaemia inhibitory factor21US 5,187,077 AAmrad Corporation Limited · 1993
- Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells17US 5,418,159 AAmrad Corporation Limited · 1995
- Transgenic mouse model for pituitary disorders associated with LIF overexpression and/or GH underexpression, and its use for testing therapeutic drugs for the conditions17US 5,824,838 ACedars-Sinai Medical Center · 1998
- Recombniant method for making leukemia inhibitor factor12US 5,427,925 AAmrad Corporation Limited · 1995
- Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells12US 8,697,444 B2ThromboGenics NV · 2014